Annual FCF
-$364.67 M
-$188.22 M-106.67%
31 December 2023
Summary:
Vaxcyte annual free cash flow is currently -$364.67 million, with the most recent change of -$188.22 million (-106.67%) on 31 December 2023. During the last 3 years, it has fallen by -$316.88 million (-663.17%). PCVX annual FCF is now -1031.10% below its all-time high of -$32.24 million, reached on 31 December 2018.PCVX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$98.79 M
+$61.59 M+38.40%
30 September 2024
Summary:
Vaxcyte quarterly free cash flow is currently -$98.79 million, with the most recent change of +$61.59 million (+38.40%) on 30 September 2024. Over the past year, it has dropped by -$33.90 million (-52.25%). PCVX quarterly FCF is now -970.64% below its all-time high of -$9.23 million, reached on 30 June 2020.PCVX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$616.24 M
-$33.90 M-5.82%
30 September 2024
Summary:
Vaxcyte TTM free cash flow is currently -$616.24 million, with the most recent change of -$33.90 million (-5.82%) on 30 September 2024. Over the past year, it has dropped by -$371.08 million (-151.37%). PCVX TTM FCF is now -6198.42% below its all-time high of -$9.78 million, reached on 31 March 2019.PCVX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCVX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -106.7% | -52.3% | -151.4% |
| 3 y3 years | -663.2% | -227.8% | -608.6% |
| 5 y5 years | -1031.1% | -937.9% | -1768.5% |
PCVX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -663.2% | at low | -227.8% | +46.9% | -608.6% | at low |
| 5 y | 5 years | -1031.1% | at low | -970.6% | +46.9% | -1768.5% | at low |
| alltime | all time | -1031.1% | at low | -970.6% | +46.9% | -6198.4% | at low |
Vaxcyte Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$98.79 M(-38.4%) | -$616.24 M(+5.8%) |
| June 2024 | - | -$160.37 M(-6.3%) | -$582.34 M(+20.7%) |
| Mar 2024 | - | -$171.20 M(-7.9%) | -$482.56 M(+32.3%) |
| Dec 2023 | -$364.67 M(+106.7%) | -$185.88 M(+186.5%) | -$364.67 M(+48.7%) |
| Sept 2023 | - | -$64.89 M(+7.1%) | -$245.16 M(+11.6%) |
| June 2023 | - | -$60.60 M(+13.7%) | -$219.66 M(+10.3%) |
| Mar 2023 | - | -$53.30 M(-19.7%) | -$199.12 M(+12.9%) |
| Dec 2022 | -$176.44 M(+37.9%) | -$66.37 M(+68.5%) | -$176.44 M(+8.5%) |
| Sept 2022 | - | -$39.39 M(-1.7%) | -$162.55 M(+6.0%) |
| June 2022 | - | -$40.06 M(+30.8%) | -$153.29 M(+6.4%) |
| Mar 2022 | - | -$30.62 M(-41.6%) | -$144.12 M(+12.6%) |
| Dec 2021 | -$127.95 M | -$52.48 M(+74.1%) | -$127.95 M(+47.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$30.13 M(-2.4%) | -$86.96 M(+24.4%) |
| June 2021 | - | -$30.89 M(+113.7%) | -$69.91 M(+44.9%) |
| Mar 2021 | - | -$14.45 M(+25.8%) | -$48.25 M(+1.0%) |
| Dec 2020 | -$47.78 M(-1.2%) | -$11.49 M(-12.2%) | -$47.78 M(-7.5%) |
| Sept 2020 | - | -$13.08 M(+41.8%) | -$51.65 M(+7.4%) |
| June 2020 | - | -$9.23 M(-34.0%) | -$48.09 M(-8.5%) |
| Mar 2020 | - | -$13.98 M(-9.0%) | -$52.54 M(+8.7%) |
| Dec 2019 | -$48.34 M(+49.9%) | -$15.36 M(+61.4%) | -$48.34 M(+46.6%) |
| Sept 2019 | - | -$9.52 M(-30.4%) | -$32.98 M(+40.6%) |
| June 2019 | - | -$13.68 M(+39.8%) | -$23.46 M(+139.8%) |
| Mar 2019 | - | -$9.78 M | -$9.78 M |
| Dec 2018 | -$32.24 M | - | - |
FAQ
- What is Vaxcyte annual free cash flow?
- What is the all time high annual FCF for Vaxcyte?
- What is Vaxcyte annual FCF year-on-year change?
- What is Vaxcyte quarterly free cash flow?
- What is the all time high quarterly FCF for Vaxcyte?
- What is Vaxcyte quarterly FCF year-on-year change?
- What is Vaxcyte TTM free cash flow?
- What is the all time high TTM FCF for Vaxcyte?
- What is Vaxcyte TTM FCF year-on-year change?
What is Vaxcyte annual free cash flow?
The current annual FCF of PCVX is -$364.67 M
What is the all time high annual FCF for Vaxcyte?
Vaxcyte all-time high annual free cash flow is -$32.24 M
What is Vaxcyte annual FCF year-on-year change?
Over the past year, PCVX annual free cash flow has changed by -$188.22 M (-106.67%)
What is Vaxcyte quarterly free cash flow?
The current quarterly FCF of PCVX is -$98.79 M
What is the all time high quarterly FCF for Vaxcyte?
Vaxcyte all-time high quarterly free cash flow is -$9.23 M
What is Vaxcyte quarterly FCF year-on-year change?
Over the past year, PCVX quarterly free cash flow has changed by -$33.90 M (-52.25%)
What is Vaxcyte TTM free cash flow?
The current TTM FCF of PCVX is -$616.24 M
What is the all time high TTM FCF for Vaxcyte?
Vaxcyte all-time high TTM free cash flow is -$9.78 M
What is Vaxcyte TTM FCF year-on-year change?
Over the past year, PCVX TTM free cash flow has changed by -$371.08 M (-151.37%)